SCHEMBL15058291

SCHEMBL15058291

CN(C)C(=O)C(F)(F)Oc1ccc(Br)c(F)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC6A4 P31645 2/20 0.35
▸ NCEH1 Q6PIU2 2/20 0.34
▸ GAA P10253 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ PDK2 Q15119 2/20 0.33
▸ KIF11 P52732 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ PDE2A O00408 2/20 0.32
▸ RAF1 P04049 1/20 0.32
▸ EGFR P00533 1/20 0.32
▸ KDR P35968 1/20 0.32
▸ RIPK1 Q13546 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ SLC6A2 P23975 1/20 0.32
▸ CYP11B1 P15538 1/20 0.32
▸ CYP11B2 P19099 1/20 0.32
▸ MCHR1 Q99705 1/20 0.31
▸ SCN9A Q15858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875096 0.82 HDAC1 (0.36) SLC6A4GAAALDH1A1PDK2RAB9A
SCHEMBL15076094 0.82 SLC6A4 (0.33) SLC6A4PDE2AEGFRKDR
SCHEMBL15056976 0.78 TDP1 (0.43) GAAALDH1A1RAB9AHTT
SCHEMBL15059514 0.77 FFAR1 (0.39) NCEH1RAB9ARIPK1HTTPKM
SCHEMBL15057124 0.76 HPGD (0.45) ALDH1A1POLBRAB9ARIPK1
SCHEMBL30377217 0.73 GPR3 (0.46) SLC6A4GAAALDH1A1POLBTHRB
SCHEMBL518353 0.73 GPR3 (0.46) SLC6A4GAAALDH1A1POLBTHRB
SCHEMBL20244888 0.72 SLC6A4 (0.39) SLC6A4GAAKIF11PDE2AEGFR
SCHEMBL31424257 0.71 APP (0.42) NCEH1GAAKIF11RIPK1HTT
SCHEMBL9318983 0.71 SLC6A4 (0.35) SLC6A4GAAALDH1A1POLBTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2794554-B1 PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES BASF SE (DE) 2016-08-17 — — EP disclosed
EP-2794554-B1 PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES BASF SE (DE) 2016-08-17 — — EP disclosed
US-9365495-B2 Process for manufacturing aryloxyacetamides BASF SE (DE) 2016-06-14 — — US disclosed
US-9365495-B2 Process for manufacturing aryloxyacetamides BASF SE (DE) 2016-06-14 — — US disclosed
US-9365495-B2 Process for manufacturing aryloxyacetamides BASF SE (DE) 2016-06-14 — — US disclosed
US-20150119572-A1 Process for Manufacturing Aryloxyacetamides BASF SE (DE) 2015-04-30 — — US disclosed
US-20150119572-A1 Process for Manufacturing Aryloxyacetamides BASF SE (DE) 2015-04-30 — — US disclosed
US-20150119572-A1 Process for Manufacturing Aryloxyacetamides BASF SE (DE) 2015-04-30 — — US disclosed
EP-2794554-A1 PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES BASF SE (DE) 2014-10-29 — — EP disclosed
WO-2013092850-A1 PROCESS FOR MANUFACTURING ARYLOXYACETAMIDES BASF SE (DE) 2013-06-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150119572-A1 Process for Manufacturing Aryloxyacetamides AADAC, CYP2E1, CYP1A2 SLC6A4 1690/4885NCEH1 2623/4885GAA 605/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback